Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Profit After Tax: 2018-2024

Historic Profit After Tax for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to -$11.8 million.

  • Pharming Group N.V's Profit After Tax rose 8824.95% to $90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.7 million, marking a year-over-year increase of 397.78%. This contributed to the annual value of -$11.8 million for FY2024, which is 12.26% down from last year.
  • Latest data reveals that Pharming Group N.V reported Profit After Tax of -$11.8 million as of FY2024, which was down 12.26% from -$10.5 million recorded in FY2023.
  • Pharming Group N.V's 5-year Profit After Tax high stood at $37.7 million for FY2020, and its period low was -$11.8 million during FY2024.
  • Over the past 3 years, Pharming Group N.V's median Profit After Tax value was -$10.5 million (recorded in 2023), while the average stood at -$2.9 million.
  • Data for Pharming Group N.V's Profit After Tax shows a maximum YoY tumbled of 177.14% (in 2023) over the last 5 years.
  • Pharming Group N.V's Profit After Tax (Yearly) stood at $37.7 million in 2020, then slumped by 57.62% to $16.0 million in 2021, then dropped by 14.52% to $13.7 million in 2022, then slumped by 177.14% to -$10.5 million in 2023, then declined by 12.26% to -$11.8 million in 2024.